Factors predictive of airflow obstruction among veterans with presumed empirical diagnosis and treatment of COPD

Chest

Volumn 147, Issue 2, 2015, Pages 369-376

  Collins, Bridget F ^a   Feemster, Laura C ^a   Rinne, Seppo T ^a   Au, David H ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; IPRATROPIUM BROMIDE; SALBUTAMOL;

AGE; AGED; AIRWAY OBSTRUCTION; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DEPRESSION; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE EXACERBATION; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HEALTH CARE FACILITY; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; OBESITY; PREDICTION; PRIORITY JOURNAL; RISK; RISK FACTOR; RURAL ACADEMIC CENTER; RURAL CLINICAL CENTER; SLEEP DISORDERED BREATHING; SMOKING; SPIROMETRY; TERTIARY CARE CENTER; UNDERWEIGHT; VETERAN; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

AGED; AIRWAY OBSTRUCTION; COMORBIDITY; FEMALE; HUMANS; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS; VETERANS;

EID: 84928345165     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.14-0672     Document Type: Article

References (43)

1. Endorsement summary: pulmonary and critical care measures. National Quality Forum website. https://www. qualityforum. org/News-And-Resources/ Endorsement-Summaries/Endorsement- Summaries. aspx. Published 2012. Accessed May 24, 2013.
2. Han MK, Kim MG, Mardon R, et al. Spirometry utilization for COPD: how do we measure up? Chest. 2007; 132 ( 2): 403-409.
3. US Department of Health and Human Services. Agency for Healthcare Research and Quality website. http://www. quality measures. ahrq. gov. Accessed May 24, 2013.
4. Vestbo J, Hurd SS, Agustí AG, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2013; 187 ( 4): 347-365.
5. Joish VN, Brady E, Stockdale W, Brixner DI, Dirani R. Evaluating diagnosis and treatment patterns of COPD in primary care. Treat Respir Med. 2006; 5 ( 4): 283-293.
6. Lee TA, Bartle B, Weiss KB. Spirometry use in clinical practice following diagnosis of COPD. Chest. 2006; 129 ( 6): 1509-1515.
7. Joo MJ, Au DH, Fitzgibbon ML, McKell J, Lee TA. Determinants of spirometry use and accuracy of COPD diagnosis in primary care. J Gen Intern Med. 2011; 26 ( 11): 1272-1277.
8. Walker PP, Mitchell P, Diamantea F, Warburton CJ, Davies L. Eff ect of primarycare spirometry on the diagnosis and management of COPD. Eur Respir J. 2006; 28 ( 5): 945-952.
9. Tinkelman DG, Price DB, Nordyke RJ, Halbert RJ. Misdiagnosis of COPD and asthma in primary care patients 40 years of age and over. J Asthma. 2006; 43 ( 1): 75-80.
10. Bolton CE, Ionescu AA, Edwards PH, Faulkner TA, Edwards SM, Shale DJ. Attaining a correct diagnosis of COPD in general practice. Respir Med. 2005; 99 ( 4): 493-500.
11. Joo MJ, Au DH, Fitzgibbon ML, Lee TA. Inhaled corticosteroids and risk of pneumonia in newly diagnosed COPD. Respir Med. 2010; 104 ( 2): 246-252.
12. Lee TA, Pickard AS, Au DH, Bartle B, Weiss KB. Risk for death associated with medications for recently diagnosed chronic obstructive pulmonary disease. Ann Intern Med. 2008; 149 ( 6): 380-390.
13. Gershon A, Croxford R, Calzavara A, et al. Cardiovascular safety of inhaled long-acting bronchodilators in individuals with chronic obstructive pulmonary disease. JAMA Intern Med. 2013;173(13):1175-1185.
14. Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general US population. Am J Respir Crit Care Med. 1999; 159 ( 1): 179-187.
15. World Health Organization. O besity: Preventing and Managing the Global Epidemic. Report of a WHO Consultation Geneva, Switzerland: World Health Organization; 2000. WHO Technical Report Series 894.
16. StataCorp. Stata Statistical Soft ware. Release 120 [soft ware]. College Station, TX: StataCorp LP; 2011.
17. Friedman MM. Older adults' symptoms and their duration before hospitalization for heart failure. Heart Lung. 1997; 26 ( 3): 169-176.
18. Parshall MB. Adult emergency visits for chronic cardiorespiratory disease: does dyspnea matter? Nurs Res. 1999; 48 ( 2): 62-70.
19. Ogale SS, Lee TA, Au DH, Boudreau DM, Sullivan SD. Cardiovascular events associated with ipratropium bromide in COPD. Chest. 2010; 137 ( 1): 13-19.
20. Lipworth BJ. Systemic adverse eff ects of inhaled corticosteroid therapy: a systematic review and meta-analysis. Arch Intern Med. 1999; 159 ( 9): 941-955.
21. Berwick DM. A user's manual for the IOM's 'Quality Chasm' report. Health Aff (Millwood). 2002; 21 (3): 80-90.
22. Walters JA, Hansen E, Mudge P, Johns DP, Walters EH, Wood-Baker R. Barriers to the use of spirometry in general practice. Aust Fam Physician. 2005; 34 ( 3): 201-203.
23. Holleman DR Jr, Simel DL. Does the clinical examination predict airfl ow limitation? JAMA. 1995; 273 ( 4): 313-319.
24. Buff els J, Degryse J, Heyrman J, Decramer M; DIDASCO Study. Offi ce spirometry signifi cantly improves early detection of COPD in general practice: the DIDASCO Study. Chest. 2004; 125 ( 4): 1394-1399.
25. Joo MJ, Sharp LK, Au DH, Lee TA, Fitzgibbon ML. Use of spirometry in the diagnosis of COPD: a qualitative study in primary care. COPD. 2013; 10 ( 4): 444-449.
26. Salinas GD, Williamson JC, Kalhan R, et al. Barriers to adherence to chronic obstructive pulmonary disease guidelines by primary care physicians. Int J Chron Obstruct Pulmon Dis. 2011;2011( 6): 171-179.
27. Yawn BP, Wollan PC. Knowledge and attitudes of family physicians coming to COPD continuing medical education. Int J Chron Obstruct Pulmon Dis. 2008; 3 ( 2): 311-317.
28. Sin DD, Jones RL, Man SF. Obesity is a risk factor for dyspnea but not for airfl ow obstruction. Arch Intern Med. 2002; 162 ( 13): 1477-1481.
29. Zwar NA, Marks GB, Hermiz O, et al. Predictors of accuracy of diagnosis of chronic obstructive pulmonary disease in general practice. Med J Aust. 2011; 195 ( 4): 168-171.
30. Walters JA, Walters EH, Nelson M, et al. Factors associated with misdiagnosis of COPD in primary care. Prim Care Respir J. 2011; 20 ( 4): 396-402.
31. Arne M, Lisspers K, Ställberg B, et al. How oft en is diagnosis of COPD confi rmed with spirometry? Respir Med. 2010; 104 ( 4): 550-556.
32. Landbo C, Prescott E, Lange P, Vestbo J, Almdal TP. Prognostic value of nutritional status in chronic obstructive pulmonary disease. A m J Respir Crit Care Med. 1999; 160 ( 6): 1856-1861.
33. Meyer PA, Mannino DM, Redd SC, Olson DR. Characteristics of adults dying with COPD. Chest. 2002; 122( 6): 2003-2008.
34. Lindberg A, Bjerg A, Rönmark E, Larsson LG, Lundbäck B. Prevalence and underdiagnosis of COPD by disease severity and the attributable fraction of smoking: report from the Obstructive Lung Disease in Northern Sweden Studies [published correction appears in Respir Med. 2007; 101(12):2569].
35. Respir Med. 2006; 100 ( 2): 264-272.
36. Mapel DW, Hurley JS, Frost FJ, Petersen HV, Picchi MA, Coultas DB. Health care utilization in chronic obstructive pulmonary disease. A case-control study in a health maintenance organization. Arch Intern Med. 2000; 160 ( 17): 2653-2658.
37. Sullivan SD, Ramsey SD, Lee TA. The economic burden of COPD. Chest. 2000; 117 ( 2-suppl): 5S-9S.
38. Bunyan A, Lee TA, Au DH, Joo MJ. Healthcare utilization associated with misdiagnosis of COPD in primary care [abstract]. Am J Respir Crit Care Med. 2013;187:A5020.
39. Martinez CH, Kim V, Chen Y, et al; COPDGene Investigators. The clinical impact of non-obstructive chronic bronchitis in current and former smokers. Respir Med. 2014; 108 (3): 491-499.
40. Han MK, Agusti A, Calverley PM, et al. Chronic obstructive pulmonary disease phenotypes: the future of COPD. Am J Respir Crit Care Med. 2010; 182 ( 5): 598-604.
41. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Global Initiative for Chronic Obstructive Lung Disease website. http://www. goldcopd. org. Published 2013. Accessed May 5, 2014.
42. Mannino DM, Th orn D, Swensen A, Holguin F. Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD. Eur Respir J. 2008; 32 ( 4): 962-969.
43. Müllerova H, Agusti A, Erqou S, Mapel DW. Cardiovascular comorbidity in COPD: systematic literature review. Chest. 2013; 144 ( 4): 1163-1178.